Biosimilar Battlefield Update: It's Getting Uglier
A confluence of negative news is causing sharp declines (or trading suspensions) in the share prices of Samsung Biologics Co., (207940...
694 Views
EM Health Care: Late Cycle Rotation
Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...
336 Views
Reality Overwhelms Creative Accounting
Bombardier Inc (BBD/B CN) has recently fallen 38%, ThyssenKrupp AG (TKA GR) 18% and Celltrion Inc (068270 KS) 30%. In each case, the market was...
377 Views
Samsung BioLogics Trade Suspension: Short Celltrion/Long Samsung C&T
The FSC said it had found intentionality behind BioLogics’ breach of accounting rules. Hence, the FSC pressed criminal charges against BioLogics...
461 Views
Korea Stock Market Monthly Recap #30 (October 2018)
The Korean stock market fell sharply in October and KOSPI is down 13% this month. Nikkei is down 9% and S&P 500 is down 8% this month as well....
510 Views